AMRS Jan 2025 5.500 put

OPR - OPR Delayed price. Currency in USD

Add to watchlist

5.37

0.00

(0.00%)

As of 11:36AM EDT. Market open.

Loading interactive chart…

PR Newswire
AMYRIS ANNOUNCES OPERATIONAL AND FINANCIAL RESTRUCTURING TO ADVANCE STRATEGIC TRANSFORMATION
Amyris, Inc. (Nasdaq: AMRS) ("Amyris" or the "Company"), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-Market™ technology platform and clean beauty consumer brands, today announced that it is moving forward with an operational and financial restructuring to further advance its ongoing strategic transformation and position the Company for long-term success.
Motley Fool
Is It Time to Buy This Year's Worst-Performing Growth Stocks?
Ready to make sense of the market's laggards? The share prices of these high-octane growth stocks are falling in 2023, so it might be time to bet on rebounds -- but only some of them.
Simply Wall St.
The past five years for Amyris (NASDAQ:AMRS) investors has not been profitable
We're definitely into long term investing, but some companies are simply bad investments over any time frame. We don't...